Reducing the disease burden in African countries and preventing the economies of those countries from lagging behind global indicators can be done through the establishment of effective healthcare systems. Such systems should be able to face current challenges and ensure that the population is healthy and fit to work. Following the implementation of international and national programmes aimed at combating infectious disease in the region, there have been increasing calls to combat heart-related diseases, cancer, and diabetes. Poorly developed healthcare infrastructure in many countries means that healthcare cannot be fully administered in rural, remote and hard-to-reach areas. The lack of qualified medical personnel further hinders timely diagnosis and treatment. One way of solving these problems is through the use of telemedical solutions and technology, along with fixed and portable equipment which harnesses artificial intelligence technology.
Will the transition to digital healthcare be able to substantially reduce the disease burden in African countries? Which of the most promising Russian telemedical solutions and artificial intelligence products in the healthcare sector can help the African region? What effect might the implementation of modern fixed and portable telemedicine equipment have?
A roadmap with a list of changes needed to achieve the goal of rapid development of innovations in healthcare was prepared by the All-Russian Patient Union within the Patient-Oriented Innovation Forum.
Julie Gerberding, Executive VP at MSD, an acknowledged international expert and professional who is responsible for population health programmes, strategic communication and regulation issues, shares her vision of future healthcare.
The HSE Center for Health Policy presents a study of the healthcare systems international experience in the context of the coronavirus pandemic. The authors consider strategies of different countries in the fight against coronavirus, as well as prospects for the development of a vaccine against COVID-19.